Found: 95
Select item for more details and to access through your institution.
Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients.
- Published in:
- Psycho-Oncology, 2007, v. 16, n. 7, p. 644, doi. 10.1002/pon.1115
- By:
- Publication type:
- Article
Immune checkpoint inhibitors plus chemotherapy in first‐line endometrial cancer treatment: Still the era of microsatellites?
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2024, v. 131, n. 8, p. 1157, doi. 10.1111/1471-0528.17749
- By:
- Publication type:
- Article
Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy.
- Published in:
- Oncologist, 2011, v. 16, n. 2, p. 228, doi. 10.1634/theoncologist.2010-0298
- By:
- Publication type:
- Article
Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions.
- Published in:
- Ultrasonography, 2022, v. 41, n. 1, p. 93, doi. 10.14366/usg.21021
- By:
- Publication type:
- Article
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 10, p. 1552, doi. 10.3390/life12101552
- By:
- Publication type:
- Article
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.968804
- By:
- Publication type:
- Article
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS / BRAF Wild-Type mCRC Patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.940523
- By:
- Publication type:
- Article
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844801
- By:
- Publication type:
- Article
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2117, doi. 10.3390/cancers15072117
- By:
- Publication type:
- Article
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5955, doi. 10.3390/cancers14235955
- By:
- Publication type:
- Article
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13 , 1941.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1052, doi. 10.3390/cancers14041052
- By:
- Publication type:
- Article
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5715, doi. 10.3390/cancers13225715
- By:
- Publication type:
- Article
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4438, doi. 10.3390/cancers13174438
- By:
- Publication type:
- Article
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1941, doi. 10.3390/cancers13081941
- By:
- Publication type:
- Article
Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1598, doi. 10.3390/cancers11101598
- By:
- Publication type:
- Article
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 859, doi. 10.3390/cancers11060859
- By:
- Publication type:
- Article
Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell'Italia Meridionale Multicenter Phase II Study.
- Published in:
- Oncology, 2011, v. 79, n. 5/6, p. 415, doi. 10.1159/000323279
- By:
- Publication type:
- Article
Adjuvant Therapy in Colon Cancer.
- Published in:
- Oncology, 2009, v. 77, p. 50, doi. 10.1159/000258496
- By:
- Publication type:
- Article
The Dark Side of the Moon: The PI3K/PTEN/AKT Pathway in Colorectal Carcinoma.
- Published in:
- Oncology, 2009, v. 77, p. 69, doi. 10.1159/000258498
- By:
- Publication type:
- Article
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2009, v. 77, p. 97, doi. 10.1159/000258501
- By:
- Publication type:
- Article
Epidoxorubicin and Double Biochemical 5-Fluorouracil Modulation with Folinic Acid and Human Lymphoblastoid Interferon in Advanced Gastric Carcinoma: A Multicentric Phase II Study of the Southern Italy Oncology Group (GOIM).
- Published in:
- Oncology, 1996, v. 53, n. 4, p. 269, doi. 10.1159/000227572
- By:
- Publication type:
- Article
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 385, doi. 10.1634/theoncologist.2018-0442
- By:
- Publication type:
- Article
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
- By:
- Publication type:
- Article
Olaparib and advanced ovarian cancer: Summary of the past and looking into the future.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1162665
- By:
- Publication type:
- Article
AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1304, doi. 10.1093/neuonc/now035
- By:
- Publication type:
- Article
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e241215, doi. 10.1001/jamanetworkopen.2024.1215
- By:
- Publication type:
- Article
Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2314144, doi. 10.1001/jamanetworkopen.2023.14144
- By:
- Publication type:
- Article
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/ Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 262, doi. 10.1016/j.cllc.2014.12.002
- By:
- Publication type:
- Article
Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34597-z
- By:
- Publication type:
- Article
Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1523, doi. 10.3390/cells9061523
- By:
- Publication type:
- Article
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.693933
- By:
- Publication type:
- Article
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
- Published in:
- Breast Journal, 2020, v. 26, n. 9, p. 1857, doi. 10.1111/tbj.13856
- By:
- Publication type:
- Article
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919899850
- By:
- Publication type:
- Article
A prospective study on survival in cancer patients with and without venous thromboembolism.
- Published in:
- Internal & Emergency Medicine, 2014, v. 9, n. 5, p. 559, doi. 10.1007/s11739-013-0985-z
- By:
- Publication type:
- Article
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0248-4
- By:
- Publication type:
- Article
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Changes in Micro RNAs Expression and Clinical Associations in Patients with Neuroendocrine Pancreatic Tumors.
- Published in:
- JOP Journal of the Pancreas, 2012, v. 13, n. 5, Supp, p. 644
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 411, doi. 10.3390/biomedicines10020411
- By:
- Publication type:
- Article
Aberrant genes promoter methylation in neural crest-derived tumors.
- Published in:
- International Journal of Biological Markers, 2012, v. 27, n. 4, p. e389, doi. 10.5301/JBM.2012.9766
- By:
- Publication type:
- Article
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 4, p. 902, doi. 10.1002/cncr.10323
- By:
- Publication type:
- Article
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 587, doi. 10.1007/s10549-017-4213-9
- By:
- Publication type:
- Article
Temporal stability of alexithymia in cancer patients following a psychological intervention.
- Published in:
- Journal of Clinical Psychology, 2011, v. 67, n. 12, p. 1177, doi. 10.1002/jclp.20839
- By:
- Publication type:
- Article
Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 623, doi. 10.3390/vaccines9060623
- By:
- Publication type:
- Article
Novel association of MEN1 gene mutations with parathyroid carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?
- Published in:
- Medical Oncology, 2013, v. 30, n. 2, p. 1, doi. 10.1007/s12032-013-0578-8
- By:
- Publication type:
- Article
CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.
- Published in:
- Cellular Oncology (2211-3428), 2012, v. 35, n. 6, p. 411, doi. 10.1007/s13402-012-0100-x
- By:
- Publication type:
- Article
Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 5, p. 435, doi. 10.1007/s13402-011-0025-9
- By:
- Publication type:
- Article